Loading...
Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis
Oncotype DX is a commercial assay frequently used for making chemotherapy decisions in estrogen receptor (ER)-positive breast cancers. The result is reported as a recurrence score ranging from 0 to 100, divided into low-risk (<18), intermediate-risk (18–30), and high-risk (≥31) categories. Our pi...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3647116/ https://ncbi.nlm.nih.gov/pubmed/23503643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2013.36 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|